163 related articles for article (PubMed ID: 31580556)
1. State of viral hepatitis care in 16 countries of Central and Eastern European Region.
Chkhartishvili N; Holban T; Simonović Babić J; Alexiev I; Matičič M; Kowalska J; Horban A;
Cent Eur J Public Health; 2019 Sep; 27(3):212-216. PubMed ID: 31580556
[TBL] [Abstract][Full Text] [Related]
2. Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017.
Lazarus JV; Stumo SR; Harris M; Hendrickx G; Hetherington KL; Maticic M; Jauffret-Roustide M; Tallada J; Simojoki K; Reic T; Safreed-Harmon K;
J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25052. PubMed ID: 29633562
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological characteristics and access to end-stage liver disease care for HIV-positive patients with HCV and/or HBV coinfections in Central/Eastern European and neighboring countries – data from the ECEE network.
Skrzat-Klapaczyńska A; Matłosz B; Otelea D; Harxhi A; Vassilenko A; Bolokadze N; Rüütel K; Papadopoulos A; Mardarescu M; Youle M; Kowalska JD; Horban A
Przegl Epidemiol; 2019; 73(1):61-68. PubMed ID: 31134775
[TBL] [Abstract][Full Text] [Related]
4. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
[TBL] [Abstract][Full Text] [Related]
5. Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV-Data from ECEE Network Group.
Aimla K; Kowalska JD; Matulionyte R; Mulabdic V; Vassilenko A; Bolokadze N; Jilich D; Antoniak S; Oprea C; Balayan T; Harxhi A; Papadopoulos A; Lakatos B; Vasylyev M; Begovac J; Yancheva N; Streinu-Cercel A; Verhaz A; Gokengin D; Dragovic G; Sojak L; Skrzat-Klapaczyńska A;
Vaccines (Basel); 2023 May; 11(5):. PubMed ID: 37243084
[TBL] [Abstract][Full Text] [Related]
6. Viral hepatitis: towards the eradication of HCV and a cure for HBV.
Asselah T; Marcellin P
Liver Int; 2015 Jan; 35 Suppl 1():1-3. PubMed ID: 25529080
[No Abstract] [Full Text] [Related]
7. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.
Hatzakis A; Wait S; Bruix J; Buti M; Carballo M; Cavaleri M; Colombo M; Delarocque-Astagneau E; Dusheiko G; Esmat G; Esteban R; Goldberg D; Gore C; Lok AS; Manns M; Marcellin P; Papatheodoridis G; Peterle A; Prati D; Piorkowsky N; Rizzetto M; Roudot-Thoraval F; Soriano V; Thomas HC; Thursz M; Valla D; van Damme P; Veldhuijzen IK; Wedemeyer H; Wiessing L; Zanetti AR; Janssen HL
J Viral Hepat; 2011 Sep; 18 Suppl 1():1-16. PubMed ID: 21824223
[TBL] [Abstract][Full Text] [Related]
8. Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries.
Leblebicioglu H; Arends JE; Ozaras R; Corti G; Santos L; Boesecke C; Ustianowski A; Duberg AS; Ruta S; Salkic NN; Husa P; Lazarevic I; Pineda JA; Pshenichnaya NY; Tsertswadze T; Matičič M; Puca E; Abuova G; Gervain J; Bayramli R; Ahmeti S; Koulentaki M; Kilani B; Vince A; Negro F; Sunbul M; Salmon D;
Antiviral Res; 2018 Feb; 150():9-14. PubMed ID: 29217468
[TBL] [Abstract][Full Text] [Related]
9. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
[TBL] [Abstract][Full Text] [Related]
10. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020.
Dunn R; Musabaev E; Razavi H; Sadirova S; Bakieva S; Razavi-Shearer K; Brigida K; Kamili S; Averhoff F; Nasrullah M
MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(34):1161-1165. PubMed ID: 32853186
[TBL] [Abstract][Full Text] [Related]
11. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
[TBL] [Abstract][Full Text] [Related]
12. Control of hepatitis B in central and eastern Europe (CEE) and the Newly Independent States (NIS): recommendations of the October 1996 meeting in Siófok, Hungary.
Meheus A
Vaccine; 1998 Nov; 16 Suppl():S99-103. PubMed ID: 9915048
[TBL] [Abstract][Full Text] [Related]
13. Impact of the 2008 economic crisis on the burden of hepatitis B and C diseases in Southern European countries.
Palladino C; Ramis R; Ezeonwumelu IJ; Biondi A; Carreras G; Fischer F; Gallus S; Golinelli D; Gorini G; Hassan S; Kabir Z; Koyanagi A; Lazarus JV; Mentis AA; Meretoja TJ; Mokdad AH; Monasta L; Mulita F; Postma MJ; Tabarés-Seisdedos R; Thiyagarajan A; Taveira N; Briz V;
BMC Public Health; 2024 Jun; 24(1):1642. PubMed ID: 38902642
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV.
Liu CJ; Chuang WL; Sheen IS; Wang HY; Chen CY; Tseng KC; Chang TT; Massetto B; Yang JC; Yun C; Knox SJ; Osinusi A; Camus G; Jiang D; Brainard DM; McHutchison JG; Hu TH; Hsu YC; Lo GH; Chu CJ; Chen JJ; Peng CY; Chien RN; Chen PJ
Gastroenterology; 2018 Mar; 154(4):989-997. PubMed ID: 29174546
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis virus infection in haemodialysis patients from Moldavia.
Covic A; Iancu L; Apetrei C; Scripcaru D; Volovat C; Mititiuc I; Covic M
Nephrol Dial Transplant; 1999 Jan; 14(1):40-5. PubMed ID: 10052474
[TBL] [Abstract][Full Text] [Related]
16. Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin.
Preda CM; Popescu CP; Baicus C; Constantinescu I; Oproiu A; Voiosu T; Diculescu M; Negreanu L; Gheorghe L; Sporea I; Trifan A; Ceausu E; Proca D; Manuc M
J Viral Hepat; 2018 Jul; 25(7):834-841. PubMed ID: 29397016
[TBL] [Abstract][Full Text] [Related]
17. Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe.
Ozaras R; Corti G; Ruta S; Lacombe K; Mondelli MU; Irwing WL; Puoti M; Khalighi A; Santos ML; Harxhi A; Lazarevic I; Soriano V; Gervain J; Leblebicioglu H; Salmon D; Arends JE;
Clin Microbiol Infect; 2015 Nov; 21(11):1027-32. PubMed ID: 26166544
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B and C surveillance and screening programmes in the non-EU/EEA Member States of the WHO European Region: survey findings from 10 countries, 2012.
Mozalevskis A; Eramova I; Safreed-Harmon K; Lazarus JV
Euro Surveill; 2016 Jun; 21(22):. PubMed ID: 27277421
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
[TBL] [Abstract][Full Text] [Related]
20. Surveillance for acute viral hepatitis - United States, 2007.
Daniels D; Grytdal S; Wasley A;
MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
